The North America Alpha Emitters Market is experiencing significant expansion, driven by increasing demand for precision oncology, advanced nuclear medicine capabilities, and ongoing innovation in radiopharmaceutical therapies. The region benefits from a strong healthcare infrastructure, rising prevalence of cancer, and growing investments in isotope production and targeted alpha therapy...